Comprehensive Notes on Eating, Sleep-Wake, Sexual, Gender Identity, Substance-Related, and Impulse-Control Disorders
Chapter 8: Eating and Sleep-Wake Disorders
Overview of Eating Disorders
Two major DSM-5 eating disorders: anorexia nervosa and bulimia nervosa.
Key features:
Severe disruptions in eating behavior.
Weight and shape disproportionately impact self-concept.
Extreme fear of gaining weight.
Strong sociocultural origins, with Western culture emphasizing thinness.
Additional DSM-5 disorder: binge eating disorder: involves binge eating without compensatory behaviors.
Obesity is considered a symptom in some disorders but not a DSM diagnosis itself; it is a growing epidemic worldwide.
Bulimia Nervosa
Binge Eating: hallmark feature involving uncontrollable consumption of large food amounts, often high in sugar, fat, or carbohydrates.
Binge episodes are associated with guilt, shame, or regret and may be hidden from family.
Compensatory behaviors are used to "make up" for binges:
Most common: purging (self-induced vomiting, diuretics, laxatives).
Also includes excessive exercise and fasting.
Medical complications:
Often maintain weight within 10% of normal.
Severe medical issues from purging: dental erosion, electrolyte imbalance, kidney failure, cardiac arrhythmias, seizures, intestinal and colon damage.
Psychological features:
Strong fear of weight gain.
Overconcern with body shape.
Common comorbid psychological disorders.
Anorexia Nervosa
Hallmark: extreme weight loss, defined as 15% below expected weight due to calorie restriction.
May include binging and purging.
Intense fear of weight gain and losing control over eating, with a relentless pursuit of thinness.
Often begins with dieting.
Associated features:
Marked disturbance in body image.
Common comorbid psychological disorders.
Most deadly mental disorder: can cause grave organ damage, especially to the heart, potentially leading to heart attacks and death.
Two subtypes:
Restricting type: weight loss primarily through dieting, fasting, or excessive exercise without binging or purging.
Binge-eating/purging type: involves recurrent episodes of binge eating or purging behavior.
Binge Eating Disorder
New DSM-5 disorder, involving recurrent binge eating without compensatory behaviors.
Many individuals are obese; some have concerns about shape and weight.
Often older than bulimia or anorexia patients.
Higher levels of psychopathology compared to obese individuals without binge eating.
Causes of Eating Disorders
Socio-cultural influences: media portrayals linking thinness to success and happiness, cultural emphasis on dieting, and changing ideals of body size.
Biological factors: partial genetic contributions and serotonin deficits related to bingeing.
Psychological factors: low personal control and self-confidence, perfectionism, distorted body image, preoccupation with food, and mood intolerance.
Integrative models consider dietary restraint, family influences, and combined biological and psychological dimensions.
Treatment of Eating Disorders
Bulimia Nervosa:
Cognitive-behavioral therapy (CBT) is treatment of choice; focuses on modifying maladaptive thoughts and behaviors related to eating and body image.
Antidepressants may reduce binging and purging, but often not effective long-term alone.
Binge Eating Disorder:
CBT is effective, similar to bulimia treatment.
Interpersonal psychotherapy also effective.
Self-help techniques show promise.
Medication previously used for obesity is no longer recommended.
Anorexia Nervosa:
Goals include weight restoration, psychoeducation, behavioral and cognitive interventions targeting food, weight, body image, and emotions.
Family-based treatment is common.
Prognosis is generally poorer than bulimia.
Obesity
Defined as body mass index (BMI) ≥ 30.
Not a DSM disorder, but often a consequence of disordered eating.
Prevalence is increasing globally, including among children and adolescents.
Related to lifestyle, technology reducing physical activity, genetic factors (~30%), and psychosocial contributors.
Associated with mortality rates close to smoking.
Disordered eating patterns common, such as night eating syndrome (eating ≥ 1/3 daily calories after dinner, awake during night eating episodes, no binging, often skipping breakfast).
Treatment of Obesity
Moderate success in adults; more success with children and adolescents.
Stepwise approach:
Self-directed weight loss programs.
Commercial self-help programs.
Behavior modification programs.
Bariatric surgery (in extreme cases).
Sleep-Wake Disorders: Overview
Two major types:
Dyssomnias: difficulties in amount, quality, or timing of sleep.
Parasomnias: abnormal behaviors or physiological events during sleep or upon waking.
Sleep is critical for immune function, daily mood, memory, attention, and concentration.
Sleep deprivation can induce depression symptoms in non-depressed people, but may have antidepressant effects in people with depression.
Assessment includes polysomnographic (PSG) evaluation (EEG, EOG, EMG) and detailed sleep history.
Dyssomnias: Specific Disorders
Insomnia Disorder
Most common sleep disorder; includes trouble falling asleep, maintaining sleep, or early awakening.
Symptoms must persist at least 3 nights per week for 3 months and cause significant distress or impairment.
Often comorbid with medical/psychological conditions; twice as frequent in females.
Unrealistic expectations about sleep and perceived sleep disruption exaggerate distress.
Hypersomnolence Disorder
Characterized by excessive sleepiness despite at least 7 hours of main sleep.
Symptoms: recurrent daytime sleep episodes, non-restorative prolonged sleep, difficulty waking fully.
Diagnosed only if not better explained by other conditions.
Commonly associated with medical and mental disorders.
Narcolepsy
Recurrent intense need for sleep or lapses into sleep, with at least one symptom among cataplexy, hypocretin deficiency, or abnormally fast REM onset (<15 min).
Rare condition (0.03%-0.16%), equal sex distribution, onset during adolescence, often improves over time.
Associated symptoms: cataplexy (brief muscle tone loss triggered by emotions), sleep paralysis, hypnagogic hallucinations.
Daytime sleepiness requires treatment and does not remit spontaneously.
Breathing-Related Sleep Disorders
Includes:
Obstructive sleep apnea hypopnea: airflow stops but respiratory effort continues.
Central sleep apnea: pauses in respiratory effort.
Sleep-related hypoventilation: decreased breathing associated with elevated CO2.
Obstructive sleep apnea affects 10-20% of the population, more common in males, those obese, and older adults.
Symptoms: snoring, sweating during sleep, frequent awakenings, morning headaches, daytime sleepiness.
Circadian Rhythm Sleep-Wake Disorder
Chronic or recurrent pattern of sleep disruption resulting from misalignment between biological circadian rhythm and environment or social schedule.
Causes insomnia, excessive sleepiness, and significant distress or impairment.
Examples: shift work type, familial type.
Suprachiasmatic nucleus (brain's biological clock) regulates melatonin and circadian rhythms, which do not strictly follow 24-hour cycles.
Medical Treatments for Sleep Disorders
Insomnia: benzodiazepines and OTC sleep medications (best for short-term use due to dependence and rebound insomnia risk).
Hypersomnia and Narcolepsy: stimulants (e.g., Ritalin) and antidepressants for cataplexy.
Breathing-related disorders: medications, weight loss, mechanical devices (e.g., CPAP).
Circadian rhythm disorders: phase delay (shift bedtime later), phase advance (earlier bedtime, harder), and bright light therapy to reset clock.
Psychological Treatments for Sleep Disorders
Cognitive Behavioral Therapy for Insomnia (CBT-I): psychoeducation, changing maladaptive beliefs, sleep diaries, improving sleep-related habits.
Relaxation and stress reduction to reduce anxiety and unrealistic sleep expectations.
Stimulus control: using bedroom only for sleep; regular bedtime routines, especially for children.
Parasomnias
Abnormal events during sleep or upon waking, divided into those occurring during:
REM sleep (dream-related)
Non-REM sleep (non-dream related)
Non-REM Sleep Arousal Disorder
Includes recurrent episodes of:
Sleep terrors: panic-like symptoms, predominantly in children, little memory, hard to awaken.
Sleepwalking (somnambulism): occurs early in sleep, person leaves bed, usually resolves spontaneously in children.
Causes distress or impairment when severe; treatments include scheduled awakenings prior to episodes.
Nightmare Disorder
Repeated intense dysphoric dreams during second half of sleep leading to distress and impairment.
More common in children (10%-50%) than adults (~1%).
Treated with antidepressants and/or relaxation training.
REM Sleep Behavior Disorder
Repeated episodes of arousal from REM sleep with vocalization or complex motor behaviors causing distress or injury.
Occurs more often during later portions of sleep.
Patient is fully alert upon awakening and not confused.
Associated with synucleinopathies (e.g., Parkinson’s disease).
Summary of Eating and Sleep Disorders
Eating disorders: characterized by gross deviations in eating, influenced by social, cultural, and psychological factors; driven largely by distorted body image and weight concerns.
Sleep disorders: interfere with normal sleep, causing impairment during wakefulness; influenced by psychological and behavioral factors.
Both categories show increasing incidence and require improved treatments.
Chapter 9: Sexual Disorders, Paraphilic Disorders, and Gender Dysphoria
Normal Sexuality and Sexual Dysfunctions
“Normal” sexual behaviors are influenced by socio-cultural factors and gender attitudes; variations exist in sexual behavior and orientation.
The sexual response cycle includes phases: desire, arousal, plateau, orgasm, resolution.
Sexual dysfunctions involve problems in desire, arousal, orgasm, or pain, lasting at least 6 months and causing significant distress or impairment.
Common Sexual Dysfunctions
Disorder | Features | DSM-5 Criteria Highlights |
|---|---|---|
Male Hypoactive Sexual Desire Disorder | Little or no sexual interest, fantasies, or activity; accounts for 50% of complaints at clinics; about 5% prevalence. | Persistent deficient sexual desire/fantasies, ≥6 months, causing distress, not explained by other factors. |
Female Sexual Interest/Arousal Disorder | Reduced sexual interest/arousal, activity, thoughts, pleasure, or sensations across most encounters. | At least 3 symptoms like absent/reduced sexual activity or sensation for ≥6 months, causing distress. |
Female Orgasmic Disorder | Delayed, absent, or decreased intensity of orgasm in most sexual encounters. | Marked delay or absence of orgasm or reduced intensity, persistent ≥6 months, causing distress. |
Genito-Pelvic Pain/Penetration Disorder | Pain during vaginal penetration, fear of pain, pelvic floor muscle tightening. | Persistent difficulty with penetration, pain, fear, or muscle tension causing distress ≥6 months. |
Premature Ejaculation | Ejaculation within about 1 minute of penetration, before desired; most common male sexual dysfunction (21% prevalence), more frequent in young men. | Persistent ejaculation within ~1 minute of penetration on nearly all occasions for ≥6 months, causing distress. |
Erectile Disorder | Difficulty achieving or maintaining an erection; sexual desire usually intact; most common male complaint increasing with age. | Persistent inability to obtain or maintain erection sufficient for sexual activity, ≥6 months, causing distress. |
Assessment of Sexual Behavior
Comprehensive clinical interview exploring sexual history, lifestyle, and contributing factors.
Medical examination to rule out physiological causes.
Psychophysiological evaluation using erotic stimuli:
Males: penile strain gauge to measure erections.
Females: vaginal photoplethysmograph to assess blood flow/arousal.
Causes of Sexual Dysfunction
Biological: physical diseases, medications, substance use (alcohol, drugs), antihypertensive medicines.
Psychological: anxiety, negative cognitions about sex, avoidance of sexual cues, distraction.
Social and Cultural: erotophobia (negative sexual attitudes), trauma, poor interpersonal communication.
Interactions among these factors are common.
Treatment of Sexual Dysfunction
Education can be significantly helpful.
Masters and Johnson psychosocial interventions: focus on sexual response education, sensate focus, nondemand pleasuring to reduce performance anxiety.
Additional therapies:
Squeeze technique for premature ejaculation.
Masturbatory training for female orgasmic disorder.
Use of vaginal dilators for vaginismus.
Exposure to erotic material for low desire.
Medical treatments primarily available for erectile dysfunction (e.g., Viagra, penile injections, implants, vascular surgery, vacuum devices).
Limited medical treatments for female dysfunctions.
Paraphilic Disorders
Characterized by sexual attraction/arousal focused on inappropriate people, objects, or situations.
High comorbidity with anxiety, mood, and substance use disorders.
Manifest as fantasies, urges, or behaviors; considered disordered only if causing distress/impairment or involving nonconsenting persons.
DSM-5 Paraphilias include:
Fetishistic disorder: sexual focus on nonliving objects or nongenital body parts.
Voyeuristic disorder: observing unsuspecting others naked or engaged in sexual activity.
Exhibitionistic disorder: exposing genitals to strangers.
Frotteuristic disorder: rubbing against nonconsenting persons.
Transvestic disorder: sexual arousal from cross-dressing.
Sexual sadism disorder: inflicting pain/humiliation for arousal.
Sexual masochism disorder: receiving pain/humiliation for arousal.
Pedophilic disorder: sexual attraction to prepubescent children.
Causes and Treatment of Paraphilic Disorders
Causes:
Difficulty with normal relationships and typical sexual experiences.
Early chance sexual associations reinforced by masturbation.
High sex drive; suppression efforts may worsen symptoms.
Treatment:
Psychosocial behavioral interventions: covert sensitization (imagining negative consequences), orgasmic reconditioning, family/marital therapy, relapse prevention.
Approximately 75%-95% improvement in treated cases; poorer outcomes in rapists or multiple paraphilias.
Drug treatments (chemical castration) like cyproterone acetate or medroxyprogesterone acetate reduce testosterone and sexual urges, often used for dangerous offenders but relapse common after cessation.
Gender Dysphoria
Marked incongruence between experienced/expressed gender and assigned gender lasting at least 6 months.
Associated with distress or impairment in social, school, or other functioning areas.
Diagnostic features differ for children (specified behaviors such as preference for cross-gender roles, toys, clothes) and adolescents/adults (desire to be rid of primary or secondary sex traits, desire to be treated as other gender).
Causes unknown; gender identity develops between 18 months and 3 years.
Not a disorder unless causing significant distress or impairment.
Treatment can include sex reassignment surgery after psychological and social stability, with 75% satisfaction reported; female-to-male transitions show better adjustment.
Controversy exists around psychological interventions for children and treatment of intersexuality.
Summary
Sexual dysfunctions are common and involve difficulties in desire, arousal, orgasm, and/or pain.
Paraphilic disorders represent inappropriate sexual attractions causing impairment or distress.
Treatments combining psychosocial and medical approaches are generally effective.
Gender dysphoria involves distress related to a mismatch of gender identity and sex assigned at birth.
Chapter 10: Substance-Related, Addictive, and Impulse-Control Disorders
Perspectives on Substance Use Disorders
Substance use: moderate consumption without significant interference.
Substance intoxication: physiological reaction to substance (e.g., being drunk).
Substance abuse: use causing danger or impairment (impacting work or relationships).
Substance dependence: characterized by tolerance (need more for effect) and withdrawal symptoms; drug-seeking behavior.
Five Main Categories of Substances
Category | Effects | Examples |
|---|---|---|
Depressants | Behavioral sedation | Alcohol, sedatives, anxiolytic drugs |
Stimulants | Increase alertness and elevate mood | Cocaine, amphetamines, nicotine, caffeine |
Opiates | Produce analgesia and euphoria | Heroin, morphine, codeine |
Hallucinogens | Alter sensory perception | Marijuana, LSD |
Other drugs | Varied effects | Inhalants, anabolic steroids, medications |
DSM-5 Substance Use Disorder Criteria
Pattern of substance use leading to clinically significant distress or impairment demonstrated by at least 2 symptoms within 12 months, including:
Using larger amounts or longer than intended.
Persistent desire or unsuccessful attempts to cut down/control use.
Excessive time spent obtaining, using or recovering.
Craving or strong urge to use.
Failure to fulfill major role obligations.
Continuing use despite social/interpersonal problems.
Reduction of important activities.
Use in physically hazardous situations.
Use despite physical/psychological problems caused or worsened by substance.
Tolerance and withdrawal symptoms.
Severity: mild (2-3 symptoms), moderate (4-5), severe (6+).
Depressants: Alcohol and Sedatives
Alcohol acts mainly on GABA neurotransmitter enhancing inhibition.
Chronic use -> intoxication, withdrawal, brain damage (dementia, Wernicke’s disease), fetal alcohol syndrome (prenatal exposure causing developmental problems).
23% of Americans report binge drinking; males use and abuse more than females.
Sedative, hypnotic, anxiolytic drugs act similarly to alcohol (also via GABA system), have similar abuse criteria.
Stimulants
Increase alertness and energy; examples: amphetamines, cocaine, nicotine, caffeine.
Amphetamines: elation, vigor, reduced fatigue by increasing norepinephrine and dopamine; followed by fatigue/depression.
Cocaine blocks dopamine reuptake; highly addictive with slow development.
Nicotine highly addictive, stimulates nicotinic acetylcholine receptors; used to self-regulate mood.
Caffeine widely used; blocks adenosine reuptake; intoxication symptoms include restlessness, nervousness, insomnia, muscle twitching, tachycardia.
Opioids
Derived from opium poppy; natural and synthetic substances providing analgesia (pain relief).
Activate enkephalins and endorphins; low doses cause euphoria, drowsiness, slowed breathing; high doses can be fatal.
Withdrawal symptoms severe and long-lasting; high HIV risk from needle sharing.
Hallucinogens
Alter perception, cause hallucinations and paranoia; examples: marijuana (THC) and LSD.
Marijuana impair motivation; withdrawal rare.
LSD effects more intense; tolerance rapid; withdrawal rare but can cause psychosis.
Other Drugs of Abuse
Inhalants: volatile solvents inhaled, causing rapid intoxication similar to alcohol, with rapid absorption and common withdrawal.
Anabolic steroids: derived from testosterone; used medically and for muscle mass; no euphoria but cause mood and physical problems.
Designer drugs: substances like ecstasy targeting recreational effects with altered sensory perception; tolerance and dependence possible.
Causes of Substance-Related Disorders
Genetics: family, twin, and adoption studies show genetic risk components; multiple genes involved.
Neurobiology: drugs affect brain’s pleasure pathway involving dopamine; GABA modulates reward system; substances inhibit anxiety neurotransmitters.
Psychological:
Positive reinforcement (euphoria) and negative reinforcement (withdrawal relief) maintain use.
Substance use as coping with negative affect.
Cognitive expectancy effects influence use; cravings triggered by cues.
Social and Cultural: exposure (media, family, peers) is necessary; cultural norms shape presentation and acceptance.
Treatment of Substance-Related Disorders
Biological interventions:
Agonist substitution: safe drugs chemically similar to abused substances (e.g., methadone, nicotine replacement).
Antagonistic treatments: block effects (e.g., naltrexone).
Aversive treatments: induce unpleasant reactions (e.g., antabuse).
Biological treatments alone are often ineffective but useful for withdrawal support.
Psychosocial treatments:
Inpatient and outpatient care, no effectiveness difference.
Support groups (Alcoholics Anonymous, Narcotics Anonymous).
Component treatments combining psychotherapy, aversion therapy, contingency management, community reinforcement, relapse prevention.
Prevention efforts increasingly focus on law enforcement rather than only education.
Gambling Disorder
Included in addictive disorders in DSM-5.
Persistent problematic gambling causing distress or impairment; four or more symptoms within 12 months (e.g., increasing stakes, irritability when stopping, preoccupation, gambling when distressed, lying, jeopardizing life opportunities, reliance on others for money).
Treatment similar to substance abuse therapies; motivation critical; high dropout rate.
Research on integrated CBT treatments ongoing.
Impulse-Control Disorders
Characterized by:
Impairment in social or occupational functioning.
Tension or anxiety before the act.
Relief or gratification after the act.
Includes:
Intermittent Explosive Disorder: recurrent aggressive outbursts causing injury or property damage; rare with few controlled treatments.
Kleptomania: urge to steal unnecessary items; highly comorbid with mood and substance disorders.
Pyromania: urge to set fires; rare diagnosis among arsonists; treatment focuses on urge identification and incompatible behaviors.
Summary of Non-Substance Addiction-Related Disorders
Involve impulsive, self-destructive behaviors impacting functioning.
Research and treatment data remain limited.
Exam 3 Possible Discussion Questions
List the five substance categories and their CNS effects with examples:
Depressants (e.g., alcohol) – cause sedation.
Stimulants (e.g., cocaine) – increase alertness and mood.
Opiates (e.g., heroin) – analgesia and euphoria.
Hallucinogens (e.g., LSD) – alter sensory perception.
Other drugs (e.g., inhalants) – varied effects.
Describe the five phases of the human sexual response cycle and differentiate sexual dysfunctions from paraphilic disorders:
Phases: desire, arousal, plateau, orgasm, resolution.
Sexual dysfunctions involve impairments in these phases causing distress.
Paraphilic disorders involve atypical sexual interests or arousals often focused on inappropriate targets.
Define paraphilia; list and define four paraphilic disorders with examples:
Paraphilia: sexual arousal from atypical objects or situations causing distress or involving nonconsenting persons.
Examples:
Fetishistic disorder – attraction to nonliving objects (e.g., shoes).
Voyeuristic disorder – observing unsuspecting people.
Exhibitionistic disorder – exposing genitals.
Pedophilic disorder – attraction to prepubescent children.
Define and compare/contrast:
Fetishistic disorder vs. Transvestic disorder: Both involve sexual arousal linked to objects or clothing; fetishism is attraction to objects/nongenital body parts, while transvestic involves cross-dressing.
Transvestic disorder vs. Gender Dysphoria: Transvestic disorder is sexual arousal tied to cross-dressing without identity conflict; gender dysphoria involves distress due to incongruence between gender identity and biological sex.
Describe bulimia nervosa and anorexia nervosa; list two anorexia subtypes; primary difference:
Bulimia nervosa: recurrent binge eating with compensatory behaviors; weight often normal or slightly elevated.
Anorexia nervosa: intense fear of weight gain with significant weight loss.
Subtypes of anorexia:
Restricting type – weight loss mainly via dieting and fasting.
Binge-eating/purging type – includes bingeing or purging episodes.
Primary difference: Anorexia involves extreme weight loss; bulimia involves normal weight with binge/purge cycles.